🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,013 results for “AB” Clear

  1. Benlysta 200 mg solution for injection in pre-filled syringe., Placebo for Belimumab Solution for Injection, 200 mg/mL. The placebo for Belimumab Solution for Injection, 200 mg/mL is provided as a sterile solution for subcutaneous (SC) injection in single-use prefilled syringes.

    GlaxoSmithKline Biologicals S.A.

    Lung Diseases, Interstitial

    phase 3 small molecule active

    1 trial

  2. Benralizumab Placebo for clinical trials is a sterile liquid solution presented in an accessorized prefilled syringe (APFS) for subcutaneous injection. Please refer to the IMPD documentation enclosed., Placebo, Fasenra 30 mg solution for injection in pre-filled syringe

    AstraZeneca AB

    Hypereosinophilic Syndrome (HES)

    phase 3 small molecule active

    1 trial

  3. Beyfortus 100 mg solution for injection in pre-filled syringe, Beyfortus 50 mg solution for injection in pre-filled syringe, Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)

    Fondazione Telethon ETS

    Respiratory Syncytial Virus (RSV)

    phase 3 small molecule active

    1 trial

  4. Biktarvy 50 mg/200 mg/25 mg film-coated tablets, PTM ISL/LEN, ISLATRAVIR/LENACAPAVIR, ISLATRAVIR/LENACAPAVIR, PTM Biktarvy

    Gilead Sciences International Limited

    HIV-1 Infection

    phase 3 small molecule active

    1 trial

  5. Bimatoprost SR

    AbbVie Deutschland GmbH & Co. KG

    Open-angle Glaucoma, Ocular Hypertension

    phase 3 small molecule active

    1 trial

  6. Biological/Vaccine

    Vertex Pharmaceuticals (Ireland) Limited

    Type 1 Diabetes

    phase 3 mab active

    1 trial

  7. Biosteron, 10 mg, tabletki, Senaxa PR, 2 mg, tabletki o przedłużonym uwalnianiu

    Pharma Mar S.A.

    Menopause, sleep disorders in the postmenopausal period

    phase 3 small molecule active

    1 trial

  8. Bortezomib STADA 2,5 mg/ml Injektionslösung, Dexamethason 0,5 mg JENAPHARM®, Empliciti 400 mg powder for concentrate for solution for infusion., Kyprolis 60 mg powder for solution for infusion, Privigen 100 mg/ml solution for infusion, Privigen 100 mg/ml solution for infusion, Imnovid 1 mg hard capsules, -, Nodexon 20 mg tabletes, Imnovid 3 mg hard capsules, Imnovid 4 mg hard capsules, Imnovid 2 mg hard capsules, Nodexon 20 mg tabletės, ELRANATAMAB, Dexamethason 4 mg JENAPHARM®

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Relapsed/Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  9. Bosulif 500 mg film-coated tablets, Olverembatinib, Bosulif 100 mg film-coated tablets

    Pharma Mar S.A.

    Chronic Phase Chronic Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  10. Breathlessness Support Service

    United Therapeutics Europe Ltd

    Breathless Patients With Any Established Underlying Medical Diagnosis

    phase 3 other active

    1 trial

  11. Brentuximab Vedotin

    Takeda Pharmaceuticals International AG

    Primary Cutaneous Anaplastic Large Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  12. Brentuximab Vedotin for Injection

    China SXT Pharmaceuticals

    Classical Hodgkin Lymphoma

    phase 3 small molecule active

    1 trial

  13. Brentuximab vedotin

    Takeda Pharmaceuticals International AG

    Diffuse Large B-cell-lymphoma

    phase 3 small molecule active

    1 trial

  14. Brief Strategic Family Therapy (BSFT)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 3 other completed

    1 trial

  15. Brief advice

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    phase 3 other completed

    1 trial

  16. Bupivacaine liposome injectable suspension 266 mg

    Pacira Ireland Limited

    Bunionectomy

    phase 3 small molecule completed

    1 trial

  17. Burosumab

    Ultragenyx UK Limited

    Hypophosphatemia

    phase 3 mab completed

    1 trial

  18. Butylphthalide soft capsule

    NovaBridge Biosciences

    Vascular Dementia

    phase 3 small molecule active

    1 trial

  19. CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, PLACEBO, CASDATIFAN

    Arcus Biosciences

    Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma

    phase 3 small molecule active

    1 trial

  20. CALCIUM FOLINATE, IRINOTECAN HYDROCHLORIDE TRIHYDRATE, BEVACIZUMAB, BEVACIZUMAB, PANITUMUMAB, SOTORASIB, FLUOROURACIL

    Amgen Technology (Ireland) UC

    Colorectal Cancer (CRC)

    phase 3 small molecule active

    1 trial

  21. CALCIUM FOLINATE, OPDIVO 10 mg/mL concentrate for solution for infusion., BNT327 20 mg ml, OXALIPLATIN, FLUOROURACIL, BNT327 50 mg ml, CAPECITABINE, CAPECITABINE

    Bristol-Myers Squibb / Pfizer EEIG

    Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

    phase 3 small molecule active

    1 trial

  22. CAM2029 (octreotide subcutaneous depot), CAM2029 (octreotide subcutaneous depot)

    Camurus AB

    Acromegaly

    phase 3 small molecule active

    1 trial

  23. CAM2029 (octreotide subcutaneous depot), SANDOSTATIN LAR 30 mg powder and solvent for suspension for injection, Somatuline Autogel 120 mg, solution for injection in a pre-filled syringe

    Camurus AB

    gastroenteropancreatic neuroendocrine tumors

    phase 3 small molecule active

    1 trial

  24. CANAKINUMAB, PEMETREXED

    Novartis Ophthalmics Europe

    Non-small cell lung cancer

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources